Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti‐CD38 cytolytic antibody TAK‐079 in healthy subjects
2020 ◽
Vol 86
(7)
◽
pp. 1314-1325
◽
2005 ◽
Vol 7
(1)
◽
pp. 124-130
◽
2016 ◽
Vol 81
(5)
◽
pp. 980-988
◽
2018 ◽
Vol 49
(2)
◽
pp. 53-58